Safety and Potential Effect of Innovative Cell-based Therapy Using Adipose-derived Stromal Vascular Fraction in Patients With Autoimmune Xerostomia

NCT05857358 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Xerostomia

Interventions

PROCEDURE: lipoaspiration
DRUG: Injection of the autologous adipose-derived stromal vascular fraction (AD-SVF)

Sponsor

Assistance Publique Hopitaux De Marseille